Newly Diagnosed Breast Cancer, Surgery Programmed
Conditions
Keywords
breast cancer, fatigue, adjuvant chemotherapy, quality of life
Brief summary
The aim of this study is to identify the determinants of cancer-related fatigue, and the long-term effect of the different adjuvants treatments will be explored. A prospective longitudinal study in women diagnosed for the first time with stage I-III breast cancer and who have undergone surgery, has been designed to meet the study aims.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* aged 18 years and older * newly diagnosed with stage I-IIIA breast adenocarcinoma * have undergone surgery * WHO performance status score equal or lower than 2 * able to provide informed consent * speak French and able to complete self-report questionnaires
Exclusion criteria
* pregnancy * bilateral breast cancer * metastatic breast cancer * patients who received neoadjuvant chemotherapy * known psychiatric disease or dementia * no previous history of cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Multidimensional Fatigue Inventory (MFI-20) questionnaire is used to assess patient's fatigue. | Breast cancer patients complete the questionnaires before surgery and at several times depending on their adjuvant treatment |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaires regarding personality traits (LOT Life Orientation Test and the trait-version of the STAI State Trait Anxiety instrument), Quality of life questionnaire(EORTC QLQ-C30), and the state-version of the STAI will be also completed. | For the LOT and the trait-version of the STAI: only before the surgery, for the QLQ-C30: before surgery and several times during adjuvant treatment and for the state-version of the STAI: several times during adjuvant treatment |
Countries
France